141 related articles for article (PubMed ID: 37000897)
21. Inhibition of post-surgery tumour recurrence via a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs.
Zhao J; Ye H; Lu Q; Wang K; Chen X; Song J; Wang H; Lu Y; Cheng M; He Z; Zhai Y; Zhang H; Sun J
J Nanobiotechnology; 2022 Feb; 20(1):62. PubMed ID: 35109878
[TBL] [Abstract][Full Text] [Related]
22. Ferritin light chain promotes the reprogramming of glioma immune microenvironment and facilitates glioma progression.
Li H; Yang C; Wei Y; Li X; Jiang W; Xu Y; Li L; Guo R; Chen D; Gao P; Zhang H; Qin H; Zhang Z; Liu X; Yan D
Theranostics; 2023; 13(11):3794-3813. PubMed ID: 37441589
[No Abstract] [Full Text] [Related]
23. Protein-Crowned Micelles for Targeted and Synergistic Tumor-Associated Macrophage Reprogramming to Enhance Cancer Treatment.
Sun JH; Liang X; Cai M; Yan L; Chen Z; Guo L; Jing L; Wang Y; Zhou D
Nano Lett; 2022 Jun; 22(11):4410-4420. PubMed ID: 35575719
[TBL] [Abstract][Full Text] [Related]
24. Injectable shear-thinning polylysine hydrogels for localized immunotherapy of gastric cancer through repolarization of tumor-associated macrophages.
Yang Y; Yang Y; Chen M; Chen J; Wang J; Ma Y; Qian H
Biomater Sci; 2021 Sep; 9(19):6597-6608. PubMed ID: 34582523
[TBL] [Abstract][Full Text] [Related]
25. Development of Toll-like Receptor Agonist-Loaded Nanoparticles as Precision Immunotherapy for Reprogramming Tumor-Associated Macrophages.
Zhang Y; Chen Y; Li J; Zhu X; Liu Y; Wang X; Wang H; Yao Y; Gao Y; Chen Z
ACS Appl Mater Interfaces; 2021 Jun; 13(21):24442-24452. PubMed ID: 34008947
[TBL] [Abstract][Full Text] [Related]
26. Selectively targeting tumor-associated macrophages and tumor cells with polymeric micelles for enhanced cancer chemo-immunotherapy.
Wei X; Liu L; Li X; Wang Y; Guo X; Zhao J; Zhou S
J Control Release; 2019 Nov; 313():42-53. PubMed ID: 31629039
[TBL] [Abstract][Full Text] [Related]
27. Injectable Immunotherapeutic Hydrogel Containing RNA-Loaded Lipid Nanoparticles Reshapes Tumor Microenvironment for Pancreatic Cancer Therapy.
Gao C; Cheng K; Li Y; Gong R; Zhao X; Nie G; Ren H
Nano Lett; 2022 Nov; 22(22):8801-8809. PubMed ID: 36251255
[TBL] [Abstract][Full Text] [Related]
28. Dual fluorescence imaging-guided programmed delivery of doxorubicin and CpG nanoparticles to modulate tumor microenvironment for effective chemo-immunotherapy.
Dong X; Yang A; Bai Y; Kong D; Lv F
Biomaterials; 2020 Feb; 230():119659. PubMed ID: 31831223
[TBL] [Abstract][Full Text] [Related]
29. An injectable and biodegradable hydrogel incorporated with photoregulated NO generators to heal MRSA-infected wounds.
Lv X; Xu Y; Ruan X; Yang D; Shao J; Hu Y; Wang W; Cai Y; Tu Y; Dong X
Acta Biomater; 2022 Jul; 146():107-118. PubMed ID: 35545186
[TBL] [Abstract][Full Text] [Related]
30. Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma.
Li TF; Li K; Zhang Q; Wang C; Yue Y; Chen Z; Yuan SJ; Liu X; Wen Y; Han M; Komatsu N; Xu YH; Zhao L; Chen X
Biomaterials; 2018 Oct; 181():35-52. PubMed ID: 30071380
[TBL] [Abstract][Full Text] [Related]
31. Hydrogel/nanoparticles-mediated cooperative combination of antiangiogenesis and immunotherapy.
Yang A; Sheng S; Bai Y; Xing G; Yu X; Zhu D; Mei L; Dong X; Lv F
Acta Biomater; 2022 Nov; 153():124-138. PubMed ID: 36179979
[TBL] [Abstract][Full Text] [Related]
32. Programming Injectable DNA Hydrogels Yields Tumor Microenvironment-Activatable and Immune-Instructive Depots for Augmented Chemo-Immunotherapy.
Fan Y; Zhan M; Liang J; Yang X; Zhang B; Shi X; Hu Y
Adv Sci (Weinh); 2023 Oct; 10(29):e2302119. PubMed ID: 37541435
[TBL] [Abstract][Full Text] [Related]
33. Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection.
Zhang J; Chen C; Li A; Jing W; Sun P; Huang X; Liu Y; Zhang S; Du W; Zhang R; Liu Y; Gong A; Wu J; Jiang X
Nat Nanotechnol; 2021 May; 16(5):538-548. PubMed ID: 33526838
[TBL] [Abstract][Full Text] [Related]
34. Polymeric indoximod based prodrug nanoparticles with doxorubicin entrapment for inducing immunogenic cell death and improving the immunotherapy of breast cancer.
Zang X; Song J; Yi X; Piyu J
J Mater Chem B; 2022 Mar; 10(12):2019-2027. PubMed ID: 35254372
[TBL] [Abstract][Full Text] [Related]
35. T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma.
Li C; Guan N; Liu F
J Neurooncol; 2023 Mar; 162(1):93-108. PubMed ID: 36854924
[TBL] [Abstract][Full Text] [Related]
36. Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel.
Dai X; Meng J; Deng S; Zhang L; Wan C; Lu L; Huang J; Hu Y; Zhang Z; Li Y; Lovell JF; Wu G; Yang K; Jin H
Theranostics; 2020; 10(7):3049-3063. PubMed ID: 32194854
[TBL] [Abstract][Full Text] [Related]
37. Polymersomes-Mediated Delivery of CSF1R Inhibitor to Tumor Associated Macrophages Promotes M2 to M1-Like Macrophage Repolarization.
Rodriguez-Perdigon M; Jimaja S; Haeni L; Bruns N; Rothen-Rutishauser B; Rüegg C
Macromol Biosci; 2022 Aug; 22(8):e2200168. PubMed ID: 35624036
[TBL] [Abstract][Full Text] [Related]
38. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.
Zhao M; Danhier F; Bastiancich C; Joudiou N; Ganipineni LP; Tsakiris N; Gallez B; Rieux AD; Jankovski A; Bianco J; Préat V
Int J Pharm; 2018 Sep; 548(1):522-529. PubMed ID: 30017818
[TBL] [Abstract][Full Text] [Related]
39. Injectable polypeptide-engineered hydrogel depot for amplifying the anti-tumor immune effect induced by chemo-photothermal therapy.
Hou XL; Dai X; Yang J; Zhang B; Zhao DH; Li CQ; Yin ZY; Zhao YD; Liu B
J Mater Chem B; 2020 Sep; 8(37):8623-8633. PubMed ID: 32821893
[TBL] [Abstract][Full Text] [Related]
40. Repolarization of glioblastoma macrophage cells using non-agonistic Dectin-1 ligand encapsulating TLR-9 agonist: plausible role in regenerative medicine against brain tumor.
Tiwari RK; Singh S; Gupta CL; Pandey P; Singh VK; Sayyed U; Shekh R; Bajpai P
Int J Neurosci; 2021 Jun; 131(6):591-598. PubMed ID: 32250189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
